Biological age acceleration and interaction with genetic predisposition in the risk of type 2 diabetes and coronary artery disease.
Abstract
Biological age (BA), compared to chronological age, offers a more accurate reflection of aging status. In this prospective UK Biobank study, BA acceleration was measured using the Klemera-Doubal method BA (KDM-BA) and Phenotypic age (PhenoAge). Cox models estimated associations of BA acceleration with incident T2D (n = 271,885) and CAD (n = 270,054). Both additive and multiplicative interactions between BA acceleration and polygenic risk score (PRS) were examined. Predictive performance was assessed by adding BA, PRS, and their interactions to traditional risk models. BA acceleration was positively associated with incident T2D (HR
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Biological age acceleration is associated with an increased risk of type 2 diabetes and coronary artery disease. This paper is relevant as it explores biological age as a potential underlying factor in age-related diseases, contributing to the understanding of aging mechanisms.
Author of this paper? Send a correction.